ATE398110T1 - 3-aminochinazolin-2,4-dione als antibakterielle mittel - Google Patents

3-aminochinazolin-2,4-dione als antibakterielle mittel

Info

Publication number
ATE398110T1
ATE398110T1 AT00984246T AT00984246T ATE398110T1 AT E398110 T1 ATE398110 T1 AT E398110T1 AT 00984246 T AT00984246 T AT 00984246T AT 00984246 T AT00984246 T AT 00984246T AT E398110 T1 ATE398110 T1 AT E398110T1
Authority
AT
Austria
Prior art keywords
aminoquinazoline
dione
antibacterial agent
antibacterial
agent
Prior art date
Application number
AT00984246T
Other languages
English (en)
Inventor
Paul Bird
Edmund Ellsworth
Dai Nguyen
Joseph SANCHEZ
Howard Showalter
Rajeshwar Singh
Michael STIER
Tuan Tran
Brian Watson
Judy Yip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE398110T1 publication Critical patent/ATE398110T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
AT00984246T 2000-01-24 2000-12-12 3-aminochinazolin-2,4-dione als antibakterielle mittel ATE398110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18

Publications (1)

Publication Number Publication Date
ATE398110T1 true ATE398110T1 (de) 2008-07-15

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00984246T ATE398110T1 (de) 2000-01-24 2000-12-12 3-aminochinazolin-2,4-dione als antibakterielle mittel

Country Status (38)

Country Link
US (2) US7094780B1 (de)
EP (1) EP1255739B1 (de)
JP (1) JP4811978B2 (de)
KR (1) KR20020067701A (de)
CN (1) CN1425008A (de)
AP (1) AP2002002603A0 (de)
AR (1) AR030186A1 (de)
AT (1) ATE398110T1 (de)
AU (1) AU783078B2 (de)
BG (1) BG107023A (de)
BR (1) BR0017010A (de)
CA (1) CA2393802C (de)
CO (1) CO5320600A1 (de)
CR (1) CR6709A (de)
DE (1) DE60039194D1 (de)
EA (1) EA005585B1 (de)
EE (1) EE200200412A (de)
ES (1) ES2304992T3 (de)
GE (1) GEP20053429B (de)
HK (1) HK1054237A1 (de)
HN (1) HN2001000009A (de)
HR (1) HRP20020696A2 (de)
HU (1) HUP0204101A3 (de)
IL (1) IL150393A0 (de)
IS (1) IS6448A (de)
MA (1) MA26866A1 (de)
MX (1) MXPA02005989A (de)
NO (1) NO20023516L (de)
OA (1) OA12316A (de)
PA (1) PA8510101A1 (de)
PE (1) PE20011060A1 (de)
PL (1) PL356837A1 (de)
SK (1) SK10572002A3 (de)
SV (1) SV2001000288A (de)
TN (1) TNSN01011A1 (de)
UY (1) UY26551A1 (de)
WO (1) WO2001053273A1 (de)
YU (1) YU55902A (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840599D1 (de) 1997-09-15 2009-04-09 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
ATE315038T1 (de) 2001-05-30 2006-02-15 Warner Lambert Co Antibakterielle mittel
WO2002102793A2 (en) * 2001-06-19 2002-12-27 Warner-Lambert Company Llc Quinazolinediones as antibacterial agents
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
EP1667994A1 (de) * 2003-09-12 2006-06-14 Warner-Lambert Company LLC Antibakterielle chinolonmittel
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
EP1687296A1 (de) * 2003-11-18 2006-08-09 Warner-Lambert Company LLC Antibakterielle aminochinazolidindionderivate
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
BRPI0607241A2 (pt) * 2005-01-26 2009-08-25 Hoffmann La Roche derivados de fenil metanona e o uso dos mesmos como inibidores do transportador de glicina 1
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
SMP200800058B (it) 2006-03-28 2009-09-07 Procter & Gamble Sali e polimorfi malati di un acido (3s, 5s) -7- [3-ammino-5-metilpiperidinil]-1-ciclopropil-1,4-diidro-8-metossi-4-osso-3-chinolincarbossilico
US7456279B2 (en) 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
MY153733A (en) * 2008-01-30 2015-03-13 Shin Poong Pharmaceutical Co Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9732083B2 (en) 2011-03-15 2017-08-15 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
KR102032934B1 (ko) * 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
ES2704744T3 (es) 2012-06-13 2019-03-19 Incyte Holdings Corp Compuestos tricíclicos sustituidos como inhibidores de FGFR
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
JP6460991B2 (ja) 2012-09-12 2019-01-30 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 抗菌剤として使用するための三環式ジャイレース阻害剤
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EA035095B1 (ru) 2013-04-19 2020-04-27 Инсайт Холдингс Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
MX373169B (es) 2015-02-20 2020-04-24 Incyte Holdings Corp Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CR20200590A (es) 2018-05-04 2021-04-26 Incyte Corp Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
MA52493A (fr) 2018-05-04 2021-03-10 Incyte Corp Sels d'un inhibiteur de fgfr
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
TWI891666B (zh) 2019-10-14 2025-08-01 美商英塞特公司 作為fgfr抑制劑之雙環雜環
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
BR112022010664A2 (pt) 2019-12-04 2022-08-16 Incyte Corp Derivados de um inibidor de fgfr
EP4069696A1 (de) 2019-12-04 2022-10-12 Incyte Corporation Tricyclische heterocyclen als fgfr-inhibitoren
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
TW202304459A (zh) 2021-04-12 2023-02-01 美商英塞特公司 包含fgfr抑制劑及nectin-4靶向劑之組合療法
WO2022261159A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
EP4352059A1 (de) 2021-06-09 2024-04-17 Incyte Corporation Tricyclische heterocyclen als fgfr-inhibitoren

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (de) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
ATE8626T1 (de) * 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) * 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
WO1994014809A1 (de) 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellierte uracilderivate
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
SI1028950T1 (en) * 1997-10-28 2003-08-31 Warner-Lambert Company Llc 7-substituted quinazolin-2,4-diones useful as antibacterial agents
AU763839B2 (en) 1998-05-26 2003-07-31 Warner-Lambert Company Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
ES2249055T3 (es) * 1998-12-11 2006-03-16 F. Hoffmann-La Roche Ag Derivados de hidrazina.

Also Published As

Publication number Publication date
US20060287308A1 (en) 2006-12-21
US20060183762A1 (en) 2006-08-17
CA2393802A1 (en) 2001-07-26
IL150393A0 (en) 2002-12-01
UY26551A1 (es) 2001-04-30
MA26866A1 (fr) 2004-12-20
HRP20020696A2 (en) 2003-12-31
AU2089901A (en) 2001-07-31
KR20020067701A (ko) 2002-08-23
PA8510101A1 (es) 2003-06-30
US7582627B2 (en) 2009-09-01
HUP0204101A2 (hu) 2003-04-28
YU55902A (sh) 2006-01-16
EE200200412A (et) 2003-10-15
IS6448A (is) 2002-06-27
CA2393802C (en) 2011-04-19
BG107023A (en) 2003-04-30
EA200200661A1 (ru) 2003-02-27
EP1255739A1 (de) 2002-11-13
SK10572002A3 (sk) 2003-10-07
JP4811978B2 (ja) 2011-11-09
HK1054237A1 (zh) 2003-11-21
CO5320600A1 (es) 2003-09-30
NO20023516D0 (no) 2002-07-23
CR6709A (es) 2003-11-25
US7094780B1 (en) 2006-08-22
NO20023516L (no) 2002-07-23
PE20011060A1 (es) 2001-10-12
BR0017010A (pt) 2002-11-05
EP1255739B1 (de) 2008-06-11
CN1425008A (zh) 2003-06-18
ES2304992T3 (es) 2008-11-01
AR030186A1 (es) 2003-08-13
HUP0204101A3 (en) 2004-05-28
WO2001053273A1 (en) 2001-07-26
AP2002002603A0 (en) 2002-09-30
DE60039194D1 (de) 2008-07-24
GEP20053429B (en) 2005-01-25
MXPA02005989A (es) 2002-10-23
JP2003520277A (ja) 2003-07-02
AU783078B2 (en) 2005-09-22
PL356837A1 (en) 2004-07-12
SV2001000288A (es) 2001-11-30
HN2001000009A (es) 2001-06-13
EA005585B1 (ru) 2005-04-28
OA12316A (en) 2006-05-15
TNSN01011A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
ATE398110T1 (de) 3-aminochinazolin-2,4-dione als antibakterielle mittel
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
DE60134094D1 (de) C7-taxanester als antitumormittel
ATE391531T1 (de) Schweisshemmende mittel
BR0214664B1 (pt) peça de vestuário absorvente.
DE60136571D1 (de) Guanidinobenzamide als mc4-r agonisten
DE60317711D1 (de) Kationische porphyrin-derivate als antibakterielle mittel
DE60106275D1 (de) Dermatologisches mittel
BR0106287B1 (pt) seringa de segurança.
DE60132618D1 (de) 4,6-diphenylpyridinderivate als entzündungshemmende mittel
BR0013417B1 (pt) composiÇço aquosa.
DE60004207D1 (de) Bizyklische oxazolidinone als antibakterielle mittel
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
NL1027545A1 (nl) Chinolonen als antibacteriele middelen.
ATE337322T1 (de) Isoxazolin-derivate als antidepressiva
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
DE50111315D1 (de) Endoparasitizide mittel
BR0110478B1 (pt) composiÇço aquosa de xampu.
DE60220799D1 (de) Hypoglykämisches mittel
DE50209313D1 (de) Selektive arylguanidinpeptide als urokinaseinhibitoren
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DE60136966D1 (de) Pflanzenstärkendes mittel
ATE287708T1 (de) 1-amino-alkylcyclohexanederivate als trypanocide mittel
NO20024502D0 (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
ES1047772Y (es) Elevador de somier total.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties